| Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019 J Zhao, Q Yuan, H Wang, W Liu, X Liao, Y Su, X Wang, J Yuan, T Li, J Li, ... Clinical infectious diseases 71 (16), 2027-2034, 2020 | 3387 | 2020 |
| Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound J Wang, T Shen, X Huang, GR Kumar, X Chen, Z Zeng, R Zhang, R Chen, ... Journal of hepatology 65 (4), 700-710, 2016 | 479 | 2016 |
| A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice J Lu, G Lu, S Tan, J Xia, H Xiong, X Yu, Q Qi, X Yu, L Li, H Yu, N Xia, ... Cell research 30 (10), 936-939, 2020 | 147 | 2020 |
| Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen TY Zhang, Q Yuan, JH Zhao, YL Zhang, LZ Yuan, Y Lan, YC Lo, CP Sun, ... Gut 65 (4), 658-671, 2016 | 141 | 2016 |
| Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection LW Song, PG Liu, CJ Liu, TY Zhang, XD Cheng, HL Wu, HC Yang, ... Clinical Microbiology and Infection 21 (2), 197-203, 2015 | 136 | 2015 |
| Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells HL Xiong, YT Wu, JL Cao, R Yang, YX Liu, J Ma, XY Qiao, XY Yao, ... Emerging microbes & infections 9 (1), 2105-2113, 2020 | 128 | 2020 |
| HBV life cycle is restricted in mouse hepatocytes expressing human NTCP H Li, Q Zhuang, Y Wang, T Zhang, J Zhao, Y Zhang, J Zhang, Y Lin, ... Cellular & molecular immunology 11 (2), 175-183, 2014 | 120 | 2014 |
| Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 … F Zhu, C Zhuang, K Chu, L Zhang, H Zhao, S Huang, Y Su, H Lin, C Yang, ... The Lancet Respiratory Medicine 10 (8), 749-760, 2022 | 96 | 2022 |
| A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 J Chen, P Wang, L Yuan, L Zhang, L Zhang, H Zhao, C Chen, X Wang, ... Science bulletin 67 (13), 1372-1387, 2022 | 75 | 2022 |
| A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters Y Wu, X Huang, L Yuan, S Wang, Y Zhang, H Xiong, R Chen, J Ma, R Qi, ... Science translational medicine 13 (606), eabg1143, 2021 | 65 | 2021 |
| Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster L Yuan, H Zhu, M Zhou, J Ma, R Chen, Y Chen, L Chen, K Wu, M Cai, ... Signal transduction and targeted therapy 6 (1), 136, 2021 | 65 | 2021 |
| A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway JF Zhang, HL Xiong, JL Cao, SJ Wang, XR Guo, BY Lin, Y Zhang, ... Theranostics 8 (2), 549, 2018 | 65 | 2018 |
| SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates T Li, Q Zheng, H Yu, D Wu, W Xue, H Xiong, X Huang, M Nie, M Yue, ... Emerging microbes & infections 9 (1), 2076-2090, 2020 | 63 | 2020 |
| HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation L Yuan, J Jiang, X Liu, Y Zhang, L Zhang, J Xin, K Wu, X Li, J Cao, X Guo, ... Gut 68 (11), 2044-2056, 2019 | 57 | 2019 |
| The gRNA-miRNA-gRNA ternary cassette combining CRISPR/Cas9 with RNAi approach strongly inhibits hepatitis B virus replication J Wang, R Chen, R Zhang, S Ding, T Zhang, Q Yuan, G Guan, X Chen, ... Theranostics 7 (12), 3090, 2017 | 55 | 2017 |
| Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants T Li, W Xue, Q Zheng, S Song, C Yang, H Xiong, S Zhang, M Hong, ... Nature communications 12 (1), 5652, 2021 | 54 | 2021 |
| A lysine-rich motif in the phosphatidylserine receptor PSR-1 mediates recognition and removal of apoptotic cells H Yang, YZ Chen, Y Zhang, X Wang, X Zhao, JI Godfroy III, Q Liang, ... Nature communications 6 (1), 5717, 2015 | 54 | 2015 |
| Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo S Yu, H Yang, T Li, H Pan, S Ren, G Luo, J Jiang, L Yu, B Chen, Y Zhang, ... Nature communications 12 (1), 5131, 2021 | 50 | 2021 |
| Antibody-mediated immunotherapy against chronic hepatitis B virus infection Y Gao, TY Zhang, Q Yuan, NS Xia Human vaccines & immunotherapeutics 13 (8), 1768-1773, 2017 | 47 | 2017 |
| Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response CL Zhuang, ZJ Lin, ZF Bi, LX Qiu, FF Hu, XH Liu, BZ Lin, YY Su, HR Pan, ... Emerging microbes & infections 10 (1), 365-375, 2021 | 44 | 2021 |
